Similar articles

• Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.

  [No authors listed] [No authors listed] Ann Pharmacother. 2006 May;40(5):1007-8. doi: 10.1345/aph.1N108. Epub 2006 May 2. Ann Pharmacother. 2006. PMID: 16670365 No abstract available.
• [Drug resistance in Mycobacteria tuberculosis in the Barents region of Russia and Norway].

  Mar'iandyshev AO, Tungusova OS, Kaugan D, Sandven P. Mar'iandyshev AO, et al. Probl Tuberk. 2002;(2):41-3. Probl Tuberk. 2002. PMID: 11899806 Russian.
• First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

  Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA. Shamaei M, et al. Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13. Int J Infect Dis. 2009. PMID: 19285897
• [Comparative genomics and anti-tuberculosis drug target discovery].

  Shi WJ, Zhang XL, Wang HH. Shi WJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2008 Jan;31(1):54-7. Zhonghua Jie He He Hu Xi Za Zhi. 2008. PMID: 18366909 Review. Chinese. No abstract available.
• Re-emergence of tuberculosis: strategies and treatment.

  Kremer L, Besra GS. Kremer L, et al. Expert Opin Investig Drugs. 2002 Feb;11(2):153-7. doi: 10.1517/13543784.11.2.153. Expert Opin Investig Drugs. 2002. PMID: 11829709 Review.